Bal Pharma Ltd.
| BSE: 524824 | Sector: Health care |
| NSE: BALPHARMA | ISIN Code: INE083D01012 |
| BSE 00:00 | 27 May | 99.25 |
-1.25 (-1.24%) |
OPEN
102.15 |
HIGH
102.15 |
LOW
98.50 |
| NSE 00:00 | 27 May | 99.45 |
-1.15 (-1.14%) |
OPEN
101.55 |
HIGH
104.00 |
LOW
97.50 |
| OPEN | 102.15 |
| PREVIOUS CLOSE | 100.50 |
| VOLUME | 2777 |
| 52-Week high | 148.50 |
| 52-Week low | 88.00 |
| P/E | 15.18 |
| Mkt Cap.(Rs cr) | 155 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Bal Pharma Ltd. (BALPHARMA) - Half Yearly Result
Particulars ( cr) |
Sep '21 | Mar '21 | Sep '20 | Mar '20 | Sep '19 |
| Net Sales/Income From Operations | 137.61 | 132.98 | 116.33 | 76.77 | 93.91 |
| Other Income | 1.44 | 1.81 | 0.88 | 2.62 | 1.01 |
| Total Income | 139.05 | 134.79 | 117.21 | 79.39 | 94.91 |
| Total Expenditure | 124.00 | 119.79 | 103.20 | 73.63 | 90.17 |
| Operating Profit | 15.05 | 15.00 | 14.01 | 5.76 | 4.74 |
| Interest | 5.59 | 6.01 | 5.95 | 5.94 | 6.61 |
| Gross Profit | 9.46 | 8.99 | 8.06 | -0.18 | -1.87 |
| Depreciation | 3.41 | 3.96 | 3.30 | 4.38 | 2.65 |
| PBT | 6.04 | 5.03 | 4.77 | -4.56 | -4.52 |
| Tax | 1.74 | -0.90 | 1.60 | 0.97 | -1.14 |
| Net Profit/(Loss) | 4.58 | 5.93 | 3.17 | -5.53 | -3.38 |
| Minority Interest After NP | - | - | - | - | - |
| Net Profit after Minority Interest | - | - | - | - | - |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit After Exceptional Items | 4.58 | 5.93 | 3.17 | -5.53 | -3.38 |
| Equity Share Capital | 14.82 | 14.82 | 14.17 | 14.17 | 14.17 |
| Reserves Excluding Revaluation Reserves | 67.60 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS | |||||
| Basic EPS | 3.09 | 4.00 | 2.24 | 0.00 | -2.38 |
| Public Share Holding | |||||
| No Of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
| Share Holding (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Promoters and Promoter Group Shareholding | |||||
| a) Pledged/Encumbered | |||||
| - Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
| - Per. of Shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| - Per. of Shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| b) Non-encumbered | |||||
| - Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| - Per. of shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Note : | PBT include deferred tax and fringe benefit tax Net profit figures include extra-ordinary items income/expenditure. | ||||
Quick Links for Bal Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
